世界の明白な肝性脳症市場：市場規模・現状・予測

• 英文タイトル：Global Overt Hepatic Encephalopathy Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9N7751
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、94ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当資料は、明白な肝性脳症のグローバル市場について調査・分析したレポートで、種類別（隠れている、あからさま）、用途別（病院、研究機関、診療所、手術センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・明白な肝性脳症の世界市場規模
・主要企業別市場シェア
・明白な肝性脳症の世界市場規模：種類別（隠れている、あからさま）
・明白な肝性脳症の世界市場規模：用途別（病院、研究機関、診療所、手術センター）
・明白な肝性脳症のアメリカ市場規模（種類別、用途別）
・明白な肝性脳症のヨーロッパ市場規模（種類別、用途別）
・明白な肝性脳症の中国市場規模（種類別、用途別）
・明白な肝性脳症の日本市場規模（種類別、用途別）
・明白な肝性脳症の東南アジア市場規模（種類別、用途別）
・明白な肝性脳症のインド市場規模（種類別、用途別）
・明白な肝性脳症の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・明白な肝性脳症の世界市場予測（2019年-2025年）
・明白な肝性脳症の地域別市場予測（2019年-2025年）
...

Hepatic encephalopathy (HE) is an altered level of consciousness as a result of liver failure. Onset may be gradual or sudden. Other symptoms may include movement problems, changes in mood, or changes in personality. In the advanced stages it can result in a coma.Overt hepatic encephalopathy develops in approximately 40% of patients with cirrhosis during their clinical care. A first episode of overtencephalopathy predicts recurrence in 40% of patients. Aggravating factors for the development of hepatic encephalopathy in advanced liver disease include infection, gastrointestinal bleeding, metabolic disturbance, and receipt of sedative medications. Genetic abnormalities affecting ammonia metabolism can also play a role.
In 2018, the global Overt Hepatic Encephalopathy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Overt Hepatic Encephalopathy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Overt Hepatic Encephalopathy development in United States, Europe and China.

The key players covered in this study
Alfa Wassermann
Cosmo Pharmaceuticals
Horizon Pharma
KannaLife Sciences
Ocer Therapeutics
Rebiotix
Spherium Biomed
Umecrine Cognition
ASKA Pharmaceutical
Mallinckrodt
Valeant

Market segment by Type, the product can be split into
Covert
Overt

Market segment by Application, split into
Hospitals
Research Institutes
Clinics
Surgical Centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Overt Hepatic Encephalopathy status, future forecast, growth opportunity, key market and key players.
To present the Overt Hepatic Encephalopathy development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Overt Hepatic Encephalopathy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Overt Hepatic Encephalopathy Market Size Growth Rate by Type (2014-2025)
1.4.2 Covert
1.4.3 Overt
1.5 Market by Application
1.5.1 Global Overt Hepatic Encephalopathy Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Research Institutes
1.5.4 Clinics
1.5.5 Surgical Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Overt Hepatic Encephalopathy Market Size
2.2 Overt Hepatic Encephalopathy Growth Trends by Regions
2.2.1 Overt Hepatic Encephalopathy Market Size by Regions (2014-2025)
2.2.2 Overt Hepatic Encephalopathy Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Overt Hepatic Encephalopathy Market Size by Manufacturers
3.1.1 Global Overt Hepatic Encephalopathy Revenue by Manufacturers (2014-2019)
3.1.2 Global Overt Hepatic Encephalopathy Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Overt Hepatic Encephalopathy Market Concentration Ratio (CR5 and HHI)
3.2 Overt Hepatic Encephalopathy Key Players Head office and Area Served
3.3 Key Players Overt Hepatic Encephalopathy Product/Solution/Service
3.4 Date of Enter into Overt Hepatic Encephalopathy Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Overt Hepatic Encephalopathy Market Size by Type (2014-2019)
4.2 Global Overt Hepatic Encephalopathy Market Size by Application (2014-2019)

5 United States
5.1 United States Overt Hepatic Encephalopathy Market Size (2014-2019)
5.2 Overt Hepatic Encephalopathy Key Players in United States
5.3 United States Overt Hepatic Encephalopathy Market Size by Type
5.4 United States Overt Hepatic Encephalopathy Market Size by Application

6 Europe
6.1 Europe Overt Hepatic Encephalopathy Market Size (2014-2019)
6.2 Overt Hepatic Encephalopathy Key Players in Europe
6.3 Europe Overt Hepatic Encephalopathy Market Size by Type
6.4 Europe Overt Hepatic Encephalopathy Market Size by Application

7 China
7.1 China Overt Hepatic Encephalopathy Market Size (2014-2019)
7.2 Overt Hepatic Encephalopathy Key Players in China
7.3 China Overt Hepatic Encephalopathy Market Size by Type
7.4 China Overt Hepatic Encephalopathy Market Size by Application

8 Japan
8.1 Japan Overt Hepatic Encephalopathy Market Size (2014-2019)
8.2 Overt Hepatic Encephalopathy Key Players in Japan
8.3 Japan Overt Hepatic Encephalopathy Market Size by Type
8.4 Japan Overt Hepatic Encephalopathy Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Overt Hepatic Encephalopathy Market Size (2014-2019)
9.2 Overt Hepatic Encephalopathy Key Players in Southeast Asia
9.3 Southeast Asia Overt Hepatic Encephalopathy Market Size by Type
9.4 Southeast Asia Overt Hepatic Encephalopathy Market Size by Application

10 India
10.1 India Overt Hepatic Encephalopathy Market Size (2014-2019)
10.2 Overt Hepatic Encephalopathy Key Players in India
10.3 India Overt Hepatic Encephalopathy Market Size by Type
10.4 India Overt Hepatic Encephalopathy Market Size by Application

11 Central & South America
11.1 Central & South America Overt Hepatic Encephalopathy Market Size (2014-2019)
11.2 Overt Hepatic Encephalopathy Key Players in Central & South America
11.3 Central & South America Overt Hepatic Encephalopathy Market Size by Type
11.4 Central & South America Overt Hepatic Encephalopathy Market Size by Application

12 International Players Profiles
12.1 Alfa Wassermann
12.1.1 Alfa Wassermann Company Details
12.1.2 Company Description and Business Overview
12.1.3 Overt Hepatic Encephalopathy Introduction
12.1.4 Alfa Wassermann Revenue in Overt Hepatic Encephalopathy Business (2014-2019)
12.1.5 Alfa Wassermann Recent Development
12.2 Cosmo Pharmaceuticals
12.2.1 Cosmo Pharmaceuticals Company Details
12.2.2 Company Description and Business Overview
12.2.3 Overt Hepatic Encephalopathy Introduction
12.2.4 Cosmo Pharmaceuticals Revenue in Overt Hepatic Encephalopathy Business (2014-2019)
12.2.5 Cosmo Pharmaceuticals Recent Development
12.3 Horizon Pharma
12.3.1 Horizon Pharma Company Details
12.3.2 Company Description and Business Overview
12.3.3 Overt Hepatic Encephalopathy Introduction
12.3.4 Horizon Pharma Revenue in Overt Hepatic Encephalopathy Business (2014-2019)
12.3.5 Horizon Pharma Recent Development
12.4 KannaLife Sciences
12.4.1 KannaLife Sciences Company Details
12.4.2 Company Description and Business Overview
12.4.3 Overt Hepatic Encephalopathy Introduction
12.4.4 KannaLife Sciences Revenue in Overt Hepatic Encephalopathy Business (2014-2019)
12.4.5 KannaLife Sciences Recent Development
12.5 Ocer Therapeutics
12.5.1 Ocer Therapeutics Company Details
12.5.2 Company Description and Business Overview
12.5.3 Overt Hepatic Encephalopathy Introduction
12.5.4 Ocer Therapeutics Revenue in Overt Hepatic Encephalopathy Business (2014-2019)
12.5.5 Ocer Therapeutics Recent Development
12.6 Rebiotix
12.6.1 Rebiotix Company Details
12.6.2 Company Description and Business Overview
12.6.3 Overt Hepatic Encephalopathy Introduction
12.6.4 Rebiotix Revenue in Overt Hepatic Encephalopathy Business (2014-2019)
12.6.5 Rebiotix Recent Development
12.7 Spherium Biomed
12.7.1 Spherium Biomed Company Details
12.7.2 Company Description and Business Overview
12.7.3 Overt Hepatic Encephalopathy Introduction
12.7.4 Spherium Biomed Revenue in Overt Hepatic Encephalopathy Business (2014-2019)
12.7.5 Spherium Biomed Recent Development
12.8 Umecrine Cognition
12.8.1 Umecrine Cognition Company Details
12.8.2 Company Description and Business Overview
12.8.3 Overt Hepatic Encephalopathy Introduction
12.8.4 Umecrine Cognition Revenue in Overt Hepatic Encephalopathy Business (2014-2019)
12.8.5 Umecrine Cognition Recent Development
12.9 ASKA Pharmaceutical
12.9.1 ASKA Pharmaceutical Company Details
12.9.2 Company Description and Business Overview
12.9.3 Overt Hepatic Encephalopathy Introduction
12.9.4 ASKA Pharmaceutical Revenue in Overt Hepatic Encephalopathy Business (2014-2019)
12.9.5 ASKA Pharmaceutical Recent Development
12.10 Mallinckrodt
12.10.1 Mallinckrodt Company Details
12.10.2 Company Description and Business Overview
12.10.3 Overt Hepatic Encephalopathy Introduction
12.10.4 Mallinckrodt Revenue in Overt Hepatic Encephalopathy Business (2014-2019)
12.10.5 Mallinckrodt Recent Development
12.11 Valeant

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Overt Hepatic Encephalopathy Key Market Segments
Table Key Players Overt Hepatic Encephalopathy Covered
Table Global Overt Hepatic Encephalopathy Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Overt Hepatic Encephalopathy Market Size Market Share by Type 2014-2025
Figure Covert Figures
Table Key Players of Covert
Figure Overt Figures
Table Key Players of Overt
Table Global Overt Hepatic Encephalopathy Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Research Institutes Case Studies
Figure Clinics Case Studies
Figure Surgical Centers Case Studies
Figure Overt Hepatic Encephalopathy Report Years Considered
Table Global Overt Hepatic Encephalopathy Market Size 2014-2025 (Million US$)
Figure Global Overt Hepatic Encephalopathy Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Overt Hepatic Encephalopathy Market Size by Regions 2014-2025 (Million US$)
Table Global Overt Hepatic Encephalopathy Market Size by Regions 2014-2019 (Million US$)
Table Global Overt Hepatic Encephalopathy Market Share by Regions 2014-2019
Figure Global Overt Hepatic Encephalopathy Market Share by Regions 2014-2019
Figure Global Overt Hepatic Encephalopathy Market Share by Regions 2019
Table Market Top Trends
Table Global Overt Hepatic Encephalopathy Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Overt Hepatic Encephalopathy Market Share by Manufacturers (2014-2019)
Figure Global Overt Hepatic Encephalopathy Market Share by Manufacturers in 2018
Table Global Overt Hepatic Encephalopathy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Overt Hepatic Encephalopathy Product/Solution/Service
Table Date of Enter into Overt Hepatic Encephalopathy Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Overt Hepatic Encephalopathy Market Size by Type (2014-2019) (Million US$)
Table Global Overt Hepatic Encephalopathy Market Size Share by Type (2014-2019)
Figure Global Overt Hepatic Encephalopathy Market Size Market Share by Type (2014-2019)
Table Global Overt Hepatic Encephalopathy Market Size by Application (2014-2019) (Million US$)
Table Global Overt Hepatic Encephalopathy Market Size Share by Application (2014-2019)
Figure Global Overt Hepatic Encephalopathy Market Size Market Share by Application (2014-2019)
Figure Global Overt Hepatic Encephalopathy Revenue Market Share by Application in 2018
Figure United States Overt Hepatic Encephalopathy Market Size 2014-2019 (Million US$)
Table United States Key Players Overt Hepatic Encephalopathy Revenue (2018-2019) (Million US$)
Table United States Key Players Overt Hepatic Encephalopathy Market Share (2018-2019)
Table United States Overt Hepatic Encephalopathy Market Size by Type (2014-2019) (Million US$)
Table United States Overt Hepatic Encephalopathy Market Share by Type (2014-2019)
Table United States Overt Hepatic Encephalopathy Market Size by Application (2014-2019) (Million US$)
Table United States Overt Hepatic Encephalopathy Market Share by Application (2014-2019)
Figure Europe Overt Hepatic Encephalopathy Market Size 2014-2019 (Million US$)
Table Europe Key Players Overt Hepatic Encephalopathy Revenue (2018-2019) (Million US$)
Table Europe Key Players Overt Hepatic Encephalopathy Market Share (2018-2019)
Table Europe Overt Hepatic Encephalopathy Market Size by Type (2014-2019) (Million US$)
Table Europe Overt Hepatic Encephalopathy Market Share by Type (2014-2019)
Table Europe Overt Hepatic Encephalopathy Market Size by Application (2014-2019) (Million US$)
Table Europe Overt Hepatic Encephalopathy Market Share by Application (2014-2019)
Figure China Overt Hepatic Encephalopathy Market Size 2014-2019 (Million US$)
Table China Key Players Overt Hepatic Encephalopathy Revenue (2018-2019) (Million US$)
Table China Key Players Overt Hepatic Encephalopathy Market Share (2018-2019)
Table China Overt Hepatic Encephalopathy Market Size by Type (2014-20189) (Million US$)
Table China Overt Hepatic Encephalopathy Market Share by Type (2014-2019)
Table China Overt Hepatic Encephalopathy Market Size by Application (2014-2019) (Million US$)
Table China Overt Hepatic Encephalopathy Market Share by Application (2014-2019)
Figure Japan Overt Hepatic Encephalopathy Market Size 2014-2019 (Million US$)
Table Japan Key Players Overt Hepatic Encephalopathy Revenue (2018-2019) (Million US$)
Table Japan Key Players Overt Hepatic Encephalopathy Market Share (2018-2019)
Table Japan Overt Hepatic Encephalopathy Market Size by Type (2014-2019) (Million US$)
Table Japan Overt Hepatic Encephalopathy Market Share by Type (2014-2019)
Table Japan Overt Hepatic Encephalopathy Market Size by Application (2014-2019) (Million US$)
Table Japan Overt Hepatic Encephalopathy Market Share by Application (2014-2019)
Figure Southeast Asia Overt Hepatic Encephalopathy Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Overt Hepatic Encephalopathy Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Overt Hepatic Encephalopathy Market Share (2018-2019)
Table Southeast Asia Overt Hepatic Encephalopathy Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Overt Hepatic Encephalopathy Market Share by Type (2014-2019)
Table Southeast Asia Overt Hepatic Encephalopathy Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Overt Hepatic Encephalopathy Market Share by Application (2014-2019)
Figure India Overt Hepatic Encephalopathy Market Size 2014-2019 (Million US$)
Table India Key Players Overt Hepatic Encephalopathy Revenue (2018-2019) (Million US$)
Table India Key Players Overt Hepatic Encephalopathy Market Share (2018-2019)
Table India Overt Hepatic Encephalopathy Market Size by Type (2014-2019) (Million US$)
Table India Overt Hepatic Encephalopathy Market Share by Type (2014-2019)
Table India Overt Hepatic Encephalopathy Market Size by Application (2014-2019) (Million US$)
Table India Overt Hepatic Encephalopathy Market Share by Application (2014-2019)
Figure Central & South America Overt Hepatic Encephalopathy Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Overt Hepatic Encephalopathy Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Overt Hepatic Encephalopathy Market Share (2018-2019)
Table Central & South America Overt Hepatic Encephalopathy Market Size by Type (2014-2019) (Million US$)
Table Central & South America Overt Hepatic Encephalopathy Market Share by Type (2014-2019)
Table Central & South America Overt Hepatic Encephalopathy Market Size by Application (2014-2019) (Million US$)
Table Central & South America Overt Hepatic Encephalopathy Market Share by Application (2014-2019)
Table Alfa Wassermann Company Details
Table Alfa Wassermann Revenue in Overt Hepatic Encephalopathy Business (2014-2019) (Million US$)
Figure Alfa Wassermann Revenue Growth Rate in Overt Hepatic Encephalopathy Business (2014-2019)
Table Alfa Wassermann Recent Development
Table Cosmo Pharmaceuticals Company Details
Table Cosmo Pharmaceuticals Revenue in Overt Hepatic Encephalopathy Business (2014-2019)(Million US$)
Figure Cosmo Pharmaceuticals Revenue Growth Rate in Overt Hepatic Encephalopathy Business (2014-2019)
Table Cosmo Pharmaceuticals Recent Development
Table Horizon Pharma Company Details
Table Horizon Pharma Revenue in Overt Hepatic Encephalopathy Business (2014-2019)(Million US$)
Figure Horizon Pharma Revenue Growth Rate in Overt Hepatic Encephalopathy Business (2014-2019)
Table Horizon Pharma Recent Development
Table KannaLife Sciences Company Details
Table KannaLife Sciences Revenue in Overt Hepatic Encephalopathy Business (2014-2019)(Million US$)
Figure KannaLife Sciences Revenue Growth Rate in Overt Hepatic Encephalopathy Business (2014-2019)
Table KannaLife Sciences Recent Development
Table Ocer Therapeutics Company Details
Table Ocer Therapeutics Revenue in Overt Hepatic Encephalopathy Business (2014-2019)(Million US$)
Figure Ocer Therapeutics Revenue Growth Rate in Overt Hepatic Encephalopathy Business (2014-2019)
Table Ocer Therapeutics Recent Development
Table Rebiotix Company Details
Table Rebiotix Revenue in Overt Hepatic Encephalopathy Business (2014-2019)(Million US$)
Figure Rebiotix Revenue Growth Rate in Overt Hepatic Encephalopathy Business (2014-2019)
Table Rebiotix Recent Development
Table Spherium Biomed Company Details
Table Spherium Biomed Revenue in Overt Hepatic Encephalopathy Business (2014-2019)(Million US$)
Figure Spherium Biomed Revenue Growth Rate in Overt Hepatic Encephalopathy Business (2014-2019)
Table Spherium Biomed Recent Development
Table Umecrine Cognition Company Details
Table Umecrine Cognition Revenue in Overt Hepatic Encephalopathy Business (2014-2019)(Million US$)
Figure Umecrine Cognition Revenue Growth Rate in Overt Hepatic Encephalopathy Business (2014-2019)
Table Umecrine Cognition Recent Development
Table ASKA Pharmaceutical Company Details
Table ASKA Pharmaceutical Revenue in Overt Hepatic Encephalopathy Business (2014-2019)(Million US$)
Figure ASKA Pharmaceutical Revenue Growth Rate in Overt Hepatic Encephalopathy Business (2014-2019)
Table ASKA Pharmaceutical Recent Development
Table Mallinckrodt Company Details
Table Mallinckrodt Revenue in Overt Hepatic Encephalopathy Business (2014-2019)(Million US$)
Figure Mallinckrodt Revenue Growth Rate in Overt Hepatic Encephalopathy Business (2014-2019)
Table Mallinckrodt Recent Development
Table Valeant Company Details
Table Global Overt Hepatic Encephalopathy Market Size by Regions (Million US$) 2019-2025
Figure Global Overt Hepatic Encephalopathy Market Size Share by Regions (2019-2025)
Figure Global Overt Hepatic Encephalopathy Market Size Share by Regions in 2025
Figure United States Overt Hepatic Encephalopathy Market Size Forecast (2019-2025)(Million USD)
Figure Europe Overt Hepatic Encephalopathy Market Size Forecast (2019-2025)(Million USD)
Figure China Overt Hepatic Encephalopathy Market Size Forecast (2019-2025)(Million USD)
Figure Japan Overt Hepatic Encephalopathy Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Overt Hepatic Encephalopathy Market Size Forecast (2019-2025)(Million USD)
Figure India Overt Hepatic Encephalopathy Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Overt Hepatic Encephalopathy Market Size Forecast (2019-2025)(Million USD)
Table Global Overt Hepatic Encephalopathy Market Size by Product (2019-2025) (Million US$)
Figure Global Overt Hepatic Encephalopathy Market Size by Product (2019-2025)
Figure Global Overt Hepatic Encephalopathy Market Size by Product in 2025
Table Global Overt Hepatic Encephalopathy Market Size by Application (2019-2025) (Million US$)
Figure Global Overt Hepatic Encephalopathy Market Size by Application (2019-2025)
Figure Global Overt Hepatic Encephalopathy Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

世界の5Gワイヤレステクノロジ市場：市場規模・現状・予測

Global 5G Wireless Technology Market Size, Status and Forecast 2019-2025
QYR9N8229 2019年6月14日 97Pages
当資料は、5Gワイヤレステクノロジのグローバル市場について調査・分析したレポートで、種類別（タイプI、タイプII）、用途別（自動車、携帯電話、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界の光原子時計市場：市場規模・現状・予測

Global Optical Atomic Clocks Market Size, Status and Forecast 2019-2025
QYR9N7711 2019年6月14日 92Pages
当資料は、光原子時計のグローバル市場について調査・分析したレポートで、種類別（タイプI、タイプII）、用途別（地上アプリケーション、宇宙アプリケーション）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
...

世界のロミプロスチム市場：市場規模・現状・予測

Global Romiplostim Market Size, Status and Forecast 2019-2025
QYR9N7982 2019年6月14日 92Pages
当資料は、ロミプロスチムのグローバル市場について調査・分析したレポートで、種類別（250 μg/0.5 mL
、500 μg/1 mL
）、用途別（大人、小児患者）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報な...

世界のエクセナチド市場：市場規模・現状・予測

Global Exenatide Market Size, Status and Forecast 2019-2025
QYR9N7180 2019年6月14日 94Pages
当資料は、エクセナチドのグローバル市場について調査・分析したレポートで、種類別（持続放出注射懸濁液、速放注射懸濁液）、用途別（病院、ドラッグストア）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界のイクサベピロン市場：市場規模・現状・予測

Global Ixabepilone Market Size, Status and Forecast 2019-2025
QYR9N7417 2019年6月14日 98Pages
当資料は、イクサベピロンのグローバル市場について調査・分析したレポートで、種類別（15MG/VIAL
、45MG/VIAL
）、用途別（病院、ドラッグストア）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含...

世界のラパチニブ市場：市場規模・現状・予測

Global Lapatinib Market Size, Status and Forecast 2019-2025
QYR9N7436 2019年6月14日 98Pages
当資料は、ラパチニブのグローバル市場について調査・分析したレポートで、種類別（250 mg錠、タイプII）、用途別（病院、ドラッグストア）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・...

世界のA2Pメッセージング市場：市場規模・現状・予測

Global A2P Messaging Market Size, Status and Forecast 2019-2025
QYR9N8232 2019年6月14日 92Pages
当資料は、A2Pメッセージングのグローバル市場について調査・分析したレポートで、種類別（グレイルートA2P SMS、OTT A2Pメッセージング、その他）、用途別（銀行業、発券業務、健康管理、コンテンツ支払い、オペレータの関与、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、イン...

世界のプレリキサフォル市場：市場規模・現状・予測

Global Plerixafor Market Size, Status and Forecast 2019-2025
QYR9N7839 2019年6月14日 93Pages
当資料は、プレリキサフォルのグローバル市場について調査・分析したレポートで、種類別（24MG / 1.2ML、タイプII）、用途別（非ホジキンリンパ腫（NHL）患者、多発性骨髄腫（MM）患者）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情...

世界の量子コンピュータ市場：市場規模・現状・予測

Global Quantum Computers Market Size, Status and Forecast 2019-2025
QYR9N7916 2019年6月14日 99Pages
当資料は、量子コンピュータのグローバル市場について調査・分析したレポートで、種類別（ゲートレベル、量子アニーリング）、用途別（計算化学、機械学習、財務の最適化、物流とスケジューリング、ドラッグデザイン、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市...

世界のレタパムリン市場：市場規模・現状・予測

Global Retapamulin Market Size, Status and Forecast 2019-2025
QYR9N7962 2019年6月14日 92Pages
当資料は、レタパムリンのグローバル市場について調査・分析したレポートで、種類別（1％軟膏（15グラムチューブ）、1％軟膏（30グラムチューブ））、用途別（病院、ドラッグストア）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれて...

世界の外来診療所市場：市場規模・現状・予測 The outpatient clinics has continued to play a significant role in management of the cognitive behavioral disorders. High-risk situations such as substance abuse, sexual offence, depression, obesity and obsessive-compulsive behavior is becoming a major concern in various countries. Management of hig…
世界の画像誘導およびロボット支援外科手術市場：市場規模・現状・予測 Robotic surgery is usually associated with minimally invasive surgery — procedures performed through tiny incisions. It is also sometimes used in certain traditional open surgical procedures.Rise in spending on medical equipment by hospitals is expected to boost the penetration of image-guided and r…
世界の非外科外側上顆炎治療市場：市場規模・現状・予測 The non surgical treatment includes extracorporeal shock wave therapy, braces, medications and physical therapies. Various anti inflammatory drugs (NSAIDS) such as ibuprofen, aspirin and cortisone are administered to control pain in lateral epicondylitis. In 2018, the global Non-surgical Lateral Epi…
世界の外科的外側上顆炎治療市場：市場規模・現状・予測 In Surgical Lateral Epicondylitis Treatment, arthroscopic surgery and open surgery are performed. In 2018, the global Surgical Lateral Epicondylitis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This repor…
世界のイラクの医療（外科手術）市場：市場規模・現状・予測 Iraq is one of the fastest growing economies in Middle East and North Africa (MENA) attributed by the flourishing oil sector that is helping the domestic government to improve health care services. The Iraq health care system is managed by mixed initiatives of public and private sector; wherein the …